Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.Explore and learn more about Conference Series : World's leading Event Organizer
As per available reports about 1open access articles, 1 conference proceedings, 1 national symposiums are presently dedicated exclusively to microbial polymers.
Extracellular polymeric substances, are high-molecular weight compounds secreted by microorganisms into their environment. EPS establish the functional and structural integrity of biofilms, and are considered the fundamental component that determines the physiochemical properties of a biofilm.
About omics-
OMICS International is an amalgamation of Open Access Publications and worldwide international science conferences and events. Established in the year 2007 with the sole aim of making the information on Sciences and technology "Open Access", OMICS International publishes 700 online open access scholarly journals in all aspects of Science, Engineering, Management and Technology journals. OMICS International has been instrumental in taking the knowledge on Science & technology to the doorsteps of ordinary men and women. Research Scholars, Students, Libraries, Educational Institutions, Research centers and the industry are main stakeholders that benefitted greatly from this knowledge dissemination. OMICS International also organizes 1000 International conferences annually across the globe, where knowledge transfer takes place through debates, round table discussions, poster presentations, workshops, symposia and exhibitions.
Scope and Importance:
EPS are mostly composed of polysaccharides (exopolysaccharides) and proteins, but include other macro-molecules such as DNA, lipids and humic substances. EPS are the construction material of bacterial settlements and either remain attached to the cell's outer surface, or are secreted into its growth medium. These compounds are important in biofilm formation and cells attachment to surfaces. EPS constitutes 50% to 90% of a biofilm's total organic matter. Exopolysaccharides are high-molecular-weight polymers that are composed of sugar residues and are secreted by a microorganism into the surrounding environment. Microorganisms synthesize a wide spectrum of multifunctional polysaccharides including intracellular polysaccharides, structural polysaccharides and extracellular polysaccharides or exopolysaccharides (EPS). Exopolysaccharides generally consist of monosaccharides and some non-carbohydrate substituents (such as acetate, pyruvate, succinate, and phosphate). Owing to the wide diversity in composition, exopolysaccharides have found multifarious applications in various food and pharmaceutical industries. Many microbial EPS provide properties that are almost identical to the gums currently in use. With innovative approaches, efforts are underway to supersede the traditionally used plant and algal gums by their microbial counterparts. Moreover, considerable progress has been made in discovering and developing new microbial EPS that possess novel industrial significance. The exopolysaccharides of some strains of lactic acid bacteria, e.g., Lactococcus lactis subsp. cremoris, contribute a gelatinous texture to fermented milk products (e.g., Viili), and these polysaccharides are also digestible. Capsular exopolysaccharides can protect pathogenic bacteria and contribute to their pathogenicity. Attachment of nitrogen-fixing bacteria to plant roots and soil particles, which is important for colonisation of rhizosphere and roots and for infection of the plant, can be mediated by exopolysaccharides as well. An example for industrial use of exopolysaccharides is the application of dextran in panettone and other breads in the bakery industry.Exopolysaccharides also have an important role in endodontic infections.
• Pseudomonas marginalis, Rhizobium spp. and Zooglea' spp.
• gellan (Aureomonas elodea and Sphingomonas paucimobilis)
• glucuronan (Sinorhizobium meliloti)
• N-acetylglucosamine (Staphylococcus epidermidis)
• N-acetyl-heparosan (Escherichia coli)
• hyaluronic acid (Streptococcus equi)
• indican (Beijerinckia indica)
• kefiran (Lactobacillus hilgardii)
• lentinan (Lentinus elodes)
• levan (Alcaligenes viscosus, Zymomonas mobilis, Bacillus subtilis) • pullulan (Aureobasidium pullulans)
• scleroglucan (Sclerotium rolfsii, Sclerotium delfinii and Sclerotium glucanicum)
• schizophyllan (Schizophylum commune)
• stewartan (Pantoea stewartii subsp. stewartii)
• succinoglycan (Alcaligenes faecalis var myxogenes, Sinorhizobium meliloti)
• xanthan (Xanthomonas campestris)
• welan (Alcaligenes spp.)
Market Analysis-
The microbiology industry totaled nearly $7.7 billion in 2012. This total is expected to grow from $8.5 billion in 2013 to $11.4 billion in 2018, with a compound annual growth rate (CAGR) of 6.1% for the five-year period, 2013 to 2018
Conferences :
1. 2nd World Congress and Expo on Applied Microbiology,
October 31- November 2, 2016 Istanbul, Turkey
2. Rare Diseases and Orphan Drugs Conference,
May 12-13, 2016 Chicago, USA
3. Infection Prevention and Control Conference,
Aug 1-2, 2016 Frankfurt, Germany
4. Human Papillomavirus Conference,
May 2-3, 2016 Chicago, USA
5. Lupus Conference,
Oct 27-28, 2016 Chicago, USA
6. Allergy Conference,
March 29-30, 2016 Valencia, Spain
7. Mycology Conference,
Sept 12-14, 2016 San Antonio, USA
8. Medical Parasitology Conference,
Oct 17-19, 2016 Houston, USA
9. 4th HIV/AIDS, STDs & STIs Conference,
Oct 3-5, 2016, Miami, USA
10. 5th Virology Conference,
Dec 1-3, 2016, Baltimore, USA
11. 2nd Influenza Conference,
Sept 12-14, 2016 Berlin, Germany
12. 2nd Parasitology Conference,
Oct 10-12, 2016 Manchester, UK
13. 6th Euro Virology Conference,
March 10-12, 2016 Madrid, Spain
14. 3rd Hepatitis and Liver Diseases Conference,
Oct 17-19, 2016 Dubai, UAE
15. 4th Epidemiology & Emerging Diseases Conference,
Oct 3-5, 2016 London, UK
16. 2nd Flu Conference,
Nov 17-19, 2016 San Francisco, USA
17. 3rd Chronic Obstructive Pulmonary Disease (COPD) Conference,
July 11-12, 2016 Brisbane, Australia
18. European Infectious Diseases Conference,
Aug 1-3, 2016 Frankfurt, Germany
19. 4th Bacteriology and Infectious Diseases Conference,
May 16-18, 2016 San Antonio, USA
20. Infectious Diseases and Diagnostic Microbiology Conference,
Oct 3-5, 2016 Vancouver, Canada
21. 2nd Retroviruses and Novel Drugs Conference,
June 30-Jul 1, 2016 Capetown, South Africa
22. 72nd Allergy, Asthma and Immunology Conference,
San Antonio, USA
23. 26th European Clinical Microbiology and Infectious Diseases Conference, Istanbul, Turkey
24. Infection Prevention and Control Conference, Tübingen, Germany
25. 17th Infectious Diseases Conference, Hyderabad, India
26. 34th Annual Infectious Diseases Conference, Sacramento, California
27. ASM-Microbe 2016
28. 17th International Conference MPMI
29. MSBJ Annual Meeting
30. Problems in Listeriosis Conference
Socities :
1. American society for Micro Biology
2. Society for General Micro Biology
3. Swiss Society for Micro Biology
4. Society for applied Microbiology
5. International Union of Microbiological societies
6. Federation of European Microbiological Societies
Companies :
• Gilead Sciences, Inc.
• Amgen, Inc.
• Celgene Corporation
• Biogen Idec, Inc.
• Regeneron Pharmaceuticals, Inc.
• Alexion Pharmaceuticals, Inc.
• Vertex Pharmaceuticals, Inc.
• Illumina, Inc.
• BioMarin Pharmaceutical, Inc.
• Agilent Technologies, Inc.
This page will be updated regularly.
This page was last updated on November 5, 2024
